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Background: Missing outcome data or the inconsistent reporting of outcome data in clinical research can affect
the quality of evidence within a systematic review. A potential solution is an agreed standardized set of outcomes
known as a core outcome set (COS) to be measured in all studies for a specific condition. We investigated the
amount of missing patient data for primary outcomes in Cochrane systematic reviews, and surveyed the
Co-ordinating Editors of Cochrane Review Groups (CRGs) on issues related to the standardization of outcomes in
their CRG’s reviews. These groups are responsible for the more than 7,000 protocols and full versions of Cochrane
Reviews that are currently available, and the several hundred new reviews published each year, presenting the
world’s largest collection of standardized systematic reviews in health care.
Methods: Using an unselected cohort of Cochrane Reviews, we calculated and presented the percentage of
missing patient data for the primary outcome measure chosen for each review published by each CRG. We also
surveyed the CRG Co-ordinating Editors to see what their policies are with regards to outcome selection and
outcomes to include in the Summary of Finding (SoF) tables in their Cochrane Reviews. They were also asked to list
the main advantages and challenges of standardizing outcomes across all reviews within their CRG.
Results: In one fifth of the 283 reviews in the sample, more than 50% of the patient data for the primary outcome
was missing. Responses to the survey were received from 90% of Co-ordinating Editors. Thirty-six percent of CRGs
have a centralized policy regarding which outcomes to include in the SoF table and 73% of Co-ordinating Editors
thought that a COS for effectiveness trials should be used routinely for a SoF table.
Conclusions: The reliability of systematic reviews, in particular meta-analyses they contain, can be improved if
more attention is paid to missing outcome data. The availability of COSs for specific health conditions might help
with this and the concept has support from the majority of Co-ordinating Editors in CRGs.
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SurveyBackground
Cochrane Reviews are systematic reviews of research in
human health care and health policy, and are internation-
ally recognized as a high quality source of evidence for de-
cision making. They bring together research evidence on
the effects of healthcare interventions or the accuracy of
diagnostic tests into the world’s largest, standardized* Correspondence: jjk@liv.ac.uk
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reproduction in any medium, provided the orcollection of systematic reviews, with more than 5,000 full
reviews and protocols for another 2,000 published to date.
Outcome selection in systematic reviews needs to be rele-
vant to patients, clinicians and policy-makers if the find-
ings of a review are to influence practice and future
research. Inconsistent choice of outcome measures in clin-
ical trials means that many meta-analyses are unable to in-
clude data from all the relevant studies. For example, the
five most accessed Cochrane Reviews in 2009, together
with the top cited review in that year, all described incon-
sistencies in the outcomes reported in eligible trials, whichl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tainties about health care that they set out to tackle [1].
An additional problem that can affect the quality of evi-
dence within a systematic review is that of missing out-
come data from all eligible trials. Missing outcome data in
trials can occur for a number of reasons. Participant data
can be missing as a result of attrition or as a result of the
selective non-reporting of an outcome in a study. Recent
research has shown that outcome reporting bias (ORB),
that is, results-based selection for publication of a subset
of the original outcome variables, is also a major problem
in randomized trials [2]. The Outcome Reporting Bias in
Trials (ORBIT) study of the impact of ORB in randomized
trials on the results of Cochrane Reviews found that ORB
is an ‘under-recognised problem that affects the conclu-
sions in a substantial proportion of Cochrane reviews’ [3].
This study found that more than half (157/283 (55%)) of
the reviews did not include full data for the review’s pri-
mary outcome of interest from all eligible trials. The me-
dian amount of review primary outcome data missing for
any reason was 10%, whereas 50% or more of the potential
data were missing in 70 (25%) reviews. In this same study,
an assessment of the impact of ORB was undertaken for
reviews with a single meta-analysis of the primary review
outcome where there was missing outcome data for a
whole study that was known or suspected of being mea-
sured but not reported. Of the 25 reviews that met these
criteria, a sensitivity analysis revealed that the conclusions
to eight of these reviews were not robust to ORB—that is,
the treatment effect estimate changed from a significant
result favoring treatment to a non-significant result. For
all the 25 reviews assessed, the median percentage change
in the treatment effect estimates after the adjustment
based on the sensitivity analysis was 39% (interquartile
range 18% to 67%) [3].
One way to reduce the amount of missing outcome
data by ensuring that eligible trials contribute usable in-
formation is the definition and implementation of an
agreed minimum set of standardized outcomes, to be
measured and reported in all trials for a particular dis-
ease or condition, referred to as a ‘Core Outcome Set’
(COS) [4,5]. Furthermore, some Cochrane Review
Groups (CRGs) now include a Summary of Findings
(SoF) table in their reviews [6]. The SoF table presents
the results of the review for up to seven outcomes that
are important to patients and aims to improve the
understanding and retrieval of key findings.
In this paper, we present results for missing data in
single review primary outcomes from the Cochrane
Reviews included in the ORBIT study. We also report
the results of a survey of the Co-ordinating Editors of
CRGs, undertaken to obtain their views on the benefits
and challenges of core outcome sets and how they might
improve the quality of the reviews in their CRG. Wewere also interested in establishing whether the amount
of missing data from a systematic review was influenced
by whether or not a CRG had a centralized policy on
outcome selection. The Co-ordinating Editors have re-
sponsibility for overseeing the work of their CRG and
deciding on the publication of each of the Cochrane
Reviews from within their CRG.
Methods
Missing data
The missing study data reported here was part of the lar-
ger ORBIT project to estimate the prevalence and effect
of outcome reporting bias in clinical trials on the pri-
mary outcomes of systematic reviews from three issues
of The Cochrane Library: issue 4, 2006; issue 1, 2007,
and issue 2, 2007. For the 283 reviews in this study, the
number of participants in each of the eligible studies
was extracted and the percentage of missing participant
data was calculated as the number of participants miss-
ing from the meta-analyses of the single review primary
outcome (as a result of the non-reporting of outcome
data in a study), as defined by the lead reviewer. Data
from reviews containing at least five eligible studies are
presented.
Survey of Co-ordinating Editors of Cochrane Review
Groups
With the exception of the Cochrane Methodology Re-
view Group (which focuses on topics relating to method-
ology, rather than healthcare interventions and tests),
the Co-ordinating Editors for the 50 CRGs (as of 2011)
were contacted and asked to participate in a short online
survey with regards to how a COS might improve the
quality of the reviews in their CRG. The survey was con-
structed using the online survey software, SurveyGizmo,
and was open for responses between 1 November 2011
and 31 July 2012. Non-responders were contacted peri-
odically if a response to the survey was not received. As
part of the survey, Co-ordinating Editors were provided
with a brief synopsis of how COSs could make it easier
for their review authors to identify appropriate outcomes
for Cochrane Reviews, and present their findings clearly
and succinctly. They were also presented with the miss-
ing data plot for all CRGs and made aware of the data
relating to their CRG. Co-ordinating Editors were asked
whether or not they had any centralized CRG policies
relating to the outcomes to include in their reviews (in-
cluding the distinction between primary and secondary
outcomes) and outcomes to include in the SoF tables
(providing one is included in the review), or whether
these decisions are left to the authors of the review. Pat-
terns in the amount of missing participant data between
CRGs with and without a centralized policy on outcome
selection were examined. Finally, Co-ordinating Editors
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trials should be used routinely for a SoF table and what
they thought were the main advantages and challenges
of standardizing outcomes across all reviews in a par-
ticular condition covered by their CRG. All advantages
and challenges were independently reviewed by two authors
(JJK and PRW) and categorized into common topics. Any
discrepancies were resolved through discussion.
Results
Of the 283 reviews included in the ORBIT study, 143,
from 40 CRGs, were included here, that is, reviews that
contained at least 5 eligible studies (Figure 1). Forty-one
(29%) reviews contained no missing patient data, while
26 (18%) had more than 50% of the patient participant
data on the single primary outcome missing from the re-
view. Accountable reasons for missing data included the
difficulty to measure certain outcomes, the diverse range
of possible outcomes to measure and disputes around
the importance and best outcomes to measure which are
both robust and reliable for use in systematic reviews. A
summary of the relevant responses with regards to the
reasons for missing outcome data that was provided by
the Co-ordinating Editors is provided in Table 1.
Responses to the survey were received from Co-
ordinating Editors for 45 (90%) of the 50 CRGs. Fourteen
Co-ordinating Editors (31%) had previously been involved
in the development of a COS and 16 (36%) were aware of
other work that has been done or is ongoing to develop a
COS for conditions relevant to their CRG. Overall, 16
(36%) CRGs have a centralized policy for outcome selec-
tion while the remaining 29 leave outcome selection and
the relative importance of outcomes chosen to theFigure 1 The percentage of missing patient data for the primary outc
(reviews first published in Issue 4, 2006 to Issue 2, 2007).discretion of the authors of the relevant review. From
Figure 1, there did not appear to be any association be-
tween the existence of a CRG policy for outcome selection
and the amount of missing data in their reviews. Similarly,
16 (36%) CRGs have a centralized policy regarding which
outcomes to include in the SoF table (14 of which had a
centralized policy for outcome selection), while 25 (56%)
left this decision to the review authors and a further four
(9%) are not yet including the SoF table in their reviews.
All four CRGs where the SoF has not yet been adopted
had no CRG policy for outcome selection but two of the
four Co-ordinating Editors were aware of ongoing COS
development work for conditions covered by their CRG.
A total of 33 (73%) Co-ordinating Editors thought that a
COS for effectiveness trials should be used routinely for a
SoF table. Reasons for this were provided by 23 Co-
ordinating Editors and included relevant outcomes mea-
sured and reported (10), comparability of outcomes (6),
improved interpretability of outcomes (4), standardization
of outcomes (2) and reduces risk of bias (1). Ten of the 12
Co-ordinating Editors who did not think a COS should be
used in the SoF table thought that the scope and diversity
of their reviews would not allow a COS to be applied
across the reviews for their CRG.
The Co-ordinating Editors listed 100 advantages and 82
challenges associated with standardizing outcomes across
reviews in their CRG (Table 2). The most common advan-
tage for having a COS was that systematic reviews or
meta-analyses would benefit from the standardization of
outcomes. The main challenges related to the process
needed to develop a COS, decisions around when a COS
should be applied and the need to persuade potential
authors of Cochrane Reviews to use the COS.ome for each review that had at least five included studies
Table 1 Responses from Cochrane review group co-editors who provided reasons for missing data in their reviews
Cochrane Review Group Explanation from Cochrane Review Group Co-Editor
Pain, Palliative Care and
Support Care
‘I think this is about right [amount of missing data]. Our scope is large and these problems are more common when
there are no received methods (e.g. rehabilitation, palliative care, complex interventions) and less common where
there is a history of methods development and consensus (e.g., headache).
Dementia and Cognitive
Impairment
‘Would suggest that it may not be possible in our CRG to specify outcomes only by the condition without reference
to the type of intervention. For example, some interventions in dementia may aim to modify the course of the
disease, and cognitive outcomes should clearly be part of a minimum outcome set in such trials; for others, such as
certain psychosocial interventions (e.g. touch and massage), modifying cognitive decline would be an unreasonable
aim, and collection of cognitive data would be unduly burdensome for patients and researchers’.
Oral Health ‘Our reviews are very diverse so we would need to develop many different core outcome groups’.
Neuromuscular Diseases ‘Neuromuscular Disease is very diverse, even sometimes within one disease. For instance some patients with Motor
Neuron Disease will have lots of spasticity and complications related to that, others flaccidity and others bulbar
involvement. Variations in outcomes chosen depend upon the focus of the intervention and the researcher. We try to
keep our outcomes fairly loosely defined - e.g. any measure of walking ability - especially in physio/fatigue/strength
training and other qualitative research areas - but even then there are some fairly abstract outcomes measured that
don’t fit in clearly’.
Renal ‘The problem is the heterogeneity of our scope. Unlike some other CRGs we are an organ-related CRG (and then
cover many orphan reviews). We cover everything from UTI (urinary tract infections) to transplantation’.
Cystic Fibrosis and Genetic
Disorders
‘One set of outcomes is not always appropriate for every trial in cystic fibrosis, e.g. for a nutritional intervention body
mass index may be appropriate. For a respiratory therapy it may be spirometry’.
Heart ‘The issue of missing data for primary outcomes may reflect the biomedical bias in many heart disease trials - so if we
have 20 RCTs in a review with a clinical primary outcome specified, it is very likely that only a few of the trials will
have reported on the clinical outcome but many more will have reported on physiological outcomes....Our scope is
much wider than many review groups, so I can envisage difficulties coming up with a core outcome set’.
Wounds ‘Our reviews cover a variety of conditions and interventions (probably most groups do) and relate to topics with quite
under-developed research cultures (nursing, dermatology, surgery) so the high levels of missing data in our field
doesn’t surprise me’.
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There is considerable variability within and between
CRGs in the amount of data that are missing for the pri-
mary outcomes chosen for a review. However, there did
not appear to be any association between the existence
of a CRG policy for outcome selection and the amount
of missing data in their reviews (Figure 1). Furthermore,
the survey of Co-ordinating Editors revealed a clear lack
of clarity and consensus on the outcomes to measure
within the specialties covered by CRGs.
The set of reviews that are reported in this study are
slightly dated. However, the reviews used came from the
earlier ORBIT study which started in 2006. The missing
participant data from the primary outcome from each
review was extracted during the ORBIT study, althoughTable 2 Advantages and challenges of standardizing outcome
Advantages n
Advantage for a systematic review/meta-analysis 39
Improves interpretation/guidance 19
Outcome likely to be more appropriate 16
Advantage for the design of a new study 13
Improves something about the outcome itself 6
Reduces outcome reporting bias 6
Reduces resource requirement 1this remained unpublished data. Presenting the data here
accompanied the Cochrane Co-Editor survey data well
and demonstrated the importance of COSs from a
reviewer perspective. A recent inspection of a random
sample of 20 of the 283 reviews used in ORBIT revealed
that only 25% (5/20) of these reviews identified new
studies for inclusion in the most updated version of the
review – this meant on average, in at least 75% of cases,
the percent missing data from the reviews used in 2006/
2007 still remains unchanged.
The suggestion that a COS should be routinely used as
part of a SoF table was well received, with most Co-
ordinating Editors believing that this would be beneficial.
The scope and diversity of reviews within some CRGs is
likely to be a barrier to the application of a COS acrosss across all reviews for a particular condition
Challenges n
Development of a COS 23
Something about scope 21
How to persuade authors/trialists/industry to implement 20
‘How’ to measure once the ‘what’ has been decided 11
Important outcomes not currently being measured 2
Resource to develop 2
Updating process 2
Conflict of interest 1
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some of the Co-ordinating Editors in these CRGs that
outcome specification for particular conditions would be
difficult without further refinement to specific popula-
tions and interventions (for example, pharmacological
versus non-pharmacological treatments).
The main advantage of a COS as suggested by the ma-
jority of Co-ordinating Editors was that the concept of a
COS would benefit the systematic review process by in-
creasing the amount of usable information for use in a
meta-analysis. The challenges that were identified appear
to reflect a lack of experience with COS, which could be
overcome with training or support materials (for example
on how to develop a COS and how to encourage others to
use it). To help with this, the Core Outcome Measures in
Effectiveness Trials (COMET) Initiative brings together
researchers interested in the development and application
of COS (www.comet-initiative.org). COMET aims to col-
late and stimulate relevant resources (both applied and
methodological), facilitate the exchange of ideas and infor-
mation, and foster methodological research. The Initiative
has three strategic goals: to increase the number of COSs
developed using evidence-based methods; to increase their
impact on the quality of research by raising awareness and
increasing their use; and to establish methods for the
development of COS [5]. This will include work with Co-
ordinating Editors and others in The Cochrane Collabor-
ation to facilitate activities within CRGs to develop COS
and to implement these within Cochrane Reviews, includ-
ing the provision of training workshops and the prepar-
ation of training materials. This work should also have
benefits for systematic reviewers outside of The Cochrane
Collaboration, who wish to maximize the impact of COS
on the quality of reviews and the research studies that they
bring together.
Conclusions
The reliability of systematic reviews, in particular meta-
analyses they contain, can be improved if more attention
is paid to missing outcome data. The availability of
COSs for specific health conditions might help with this
and the concept has support from the majority of Co-
ordinating Editors in CRGs.
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